Literature DB >> 24641323

GABAB receptors in the bladder and bowel: therapeutic potential for positive allosteric modulators?: Commentary on Kalinichev et al., Br J Pharmacol 171: 995-1006.

Niall P Hyland1,2, Anna V Golubeva1.   

Abstract

LINKED ARTICLE: This article is a Commentary on Kalinichev M, Palea S, Haddouk H, Royer-Urios I, Guilloteau V, Lluel P, Schneider M, Saporito M and Poli S (2014). ADX71441, a novel, potent and selective positive allosteric modulator of the GABAB receptor, shows efficacy in rodent models of overactive bladder. Br J Pharmacol 171: 995-1006. doi: 10.1111/bph.12517.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  GABAB receptor; bladder pain syndrome; colon; gastrointestinal; irritable bowel syndrome; motility; positive allosteric modulator; visceral hypersensitivity

Year:  2015        PMID: 24641323      PMCID: PMC4562517          DOI: 10.1111/bph.12617

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

Review 1.  Changes in afferent activity after spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Modulation of detrusor contraction strength and micturition characteristics by intrathecal baclofen in anesthetized rats.

Authors:  T Watanabe; I Perkash; C E Constantinou
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

4.  The postganglionic excitatory innervation of the mouse urinary bladder and its modulation by prejunctional GABAB receptors.

Authors:  P Santicioli; C A Maggi; A Meli
Journal:  J Auton Pharmacol       Date:  1986-03

5.  GABA(B) receptor function in the ileum and urinary bladder of wildtype and GABA(B1) subunit null mice.

Authors:  G J Sanger; M L Munonyara; N Dass; H Prosser; M N Pangalos; M E Parsons
Journal:  Auton Autacoid Pharmacol       Date:  2002-06

6.  The GABA(B) receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats.

Authors:  Mikael Brusberg; Anna Ravnefjord; Rakel Martinsson; Håkan Larsson; Vicente Martinez; Erik Lindström
Journal:  Neuropharmacology       Date:  2008-09-25       Impact factor: 5.250

7.  Neuronal GABA release and GABA inhibition of ACh release in guinea pig urinary bladder.

Authors:  M Kusunoki; K Taniyama; C Tanaka
Journal:  Am J Physiol       Date:  1984-04

8.  ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.

Authors:  M Kalinichev; S Palea; H Haddouk; I Royer-Urios; V Guilloteau; P Lluel; M Schneider; M Saporito; S Poli
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  A Gut Feeling about GABA: Focus on GABA(B) Receptors.

Authors:  Niall P Hyland; John F Cryan
Journal:  Front Pharmacol       Date:  2010-10-04       Impact factor: 5.810

10.  The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  2 in total

Review 1.  Irritable bowel syndrome, the microbiota and the gut-brain axis.

Authors:  Hans Raskov; Jakob Burcharth; Hans-Christian Pommergaard; Jacob Rosenberg
Journal:  Gut Microbes       Date:  2016-07-29

Review 2.  Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.

Authors:  Rachel D Moloney; Siobhain M O'Mahony; Timothy G Dinan; John F Cryan
Journal:  Front Psychiatry       Date:  2015-02-16       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.